Allergan Receives FDA Approval for Juvéderm Voluma XC for Mid-face Injection via Cannula

Posted By American Med Spa Association, Wednesday, September 11, 2019

Allergan plc has announced it received U.S. Food and Drug Administration (FDA) approval for the use of Juvéderm Voluma XC, a hyaluronic acid gel dermal filler, with a TSK Steriglide cannula for cheek augmentation to correct age-related volume deficit in the mid-face in adults over 21. A cannula is a thin, flexible tube with a rounded tip that can serve as an effective delivery system. Use of a cannula allows for injection of Juvéderm Voluma XC in the cheek area. The TSK Steriglide has a unique design compared to other cannulas available on the market and features a patented tip design with a near-tip delivery port for precise product placement.
Read more at PR Newswire >>